I've been digging up news articles on NGIO Ii-key vaccines in the past to see what we had done previously with human trials. Looks like we tested an H5N1 vaccine in 120 people and it was successful. This is very key because a lot of vaccines that are being developed now have not even had animal testing yet, let alone human testing.

Quote:

---

NuGenerex Immuno-Oncology said clinical trials of Ii-Key peptide vaccines have shown that the vaccines are safe and have long-lasting immune responses. One early-stage trial tested a series of vaccine peptides for H5N1 bird flu virus in more than 120 participants.

---